High Seroprevalence of SARS-CoV-2 in Kenyan Blood Donors As of late July 2020, only 3% of recorded deaths due to COVID-19 have occurred in Africa despite being home… November 25, 2020
FDA Issues Emergency Use Authorization for SARS-CoV-2 Monoclonal Antibody Therapy Approximately 10% of COVID-19 cases lead to severe respiratory distress and hospitalization. In an effort to develop specific therapeutic options… November 17, 2020
Transfusion-Transmission of Hepatitis E from Solvent/Detergent-Treated Plasma Scientists in France recently found evidence for possible hepatitis E virus (HEV) transmission in plasma treated with solvent/detergent from two… November 11, 2020
Neutralizing Antibodies to SARS-CoV-2 Persist for at Least 5 Months Since December 2019, SARS-CoV-2 has infected over 46 million individuals worldwide leading to over 1 million deaths. While the majority… November 3, 2020
Cochrane Living Systematic Review: More Data Needed to Determine Efficacy of COVID-19 Convalescent Plasma Researchers from the Cochrane Library are performing monthly systematic reviews to evaluate the current data on the effectiveness of COVID-19… October 28, 2020
No Evidence of SARS-CoV-2 Transfusion Transmission or Viral Infectivity About 20-25% of individuals infected with SARS-CoV-2 develop severe symptoms, but many infected individuals are asymptomatic and may donate blood… October 21, 2020
Meta-Analysis Examines Leukapheresis in Patients with Acute Myeloid Leukemia and Hyperleukocytosis Hyperleukocytosis (a white blood cell count greater than 100 X 109/L) is a medical emergency with a mortality rate up… October 14, 2020
Serosurveillance of SARS-CoV-2 from Blood Donations across the U.S. The RESPONSE (REDS-IV-P Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic) Study aims to screen blood donations and monitor… October 7, 2020
COVID-19 Pandemic Impacts Blood Donation Trends In order to assess the effect of the COVID-19 pandemic on blood donations, researchers at OneBlood in Florida reviewed 264,593… October 7, 2020
COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies With few drugs to combat SARS-CoV-2 infections and the approval from the U.S. FDA for Emergency Use Authorization of COVID-19… September 30, 2020
